Islam Mohamed Hewidy

Islam Mohamed Hewidy

Auto-generated profile, based on publicly available information

Islam Mohamed Hewidy

Adjunct Faculty at Physical Therapy Department, New York Medical College, Valhalla, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2023 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
NANancy H. Aboelnour
Nancy H. Aboelnour
FKFatmaAlzahraa H. Kamel
FatmaAlzahraa H. Kamel
MBMaged A Basha
Maged A Basha
AAAlshimaa R. Azab
Alshimaa R. Azab
IHIslam M. Hewidy
Islam M. Hewidy
NKNoha M. Kamel
Noha M. Kamel
Purpose: The main aim of the trial was to assess the combined impact of graded Thera-Band strengthening exercises and scapular stabilization exercises on shoulder pain, physical function, and quality of life (QoL) in post-mastectomy adhesive capsulitis (AC). Methods: Seventy females with unilateral post-mastectomy AC partook in the trial. Participants were subdivided equally into two groups at random. Both groups obtained the traditional physical therapy program; in addition, the intervention group received graded Thera-Band exercises for shoulder muscles and scapular stabilization exercises 5 days a week for 8 weeks. Range of motion (ROM) and muscle power of shoulder were assessed by digital goniometer and handheld dynamometer, respectively. Disability of the Arm, Shoulder, and Hand questionnaire (DASH) was utilized for assessment of shoulder function and visual analogue scale (VAS) for pain measurement while short-form (SF-36) for QoL assessment. All evaluation data was recorded prior to the trial and at the eighth week of interventions for both groups. Results: All participants achieved improvements in shoulder ROM, muscle power, pain, and all aspects of QoL; however, higher statistical improvements were reported in all measurements with respect to strengthening exercises group (p < 0.001). Conclusion: The addition of graded Thera-Band strengthening exercises and scapular stabilization exercises in post-mastectomy AC rehabilitation program has significant benefits in shoulder function and patients’ QoL. Trial registration: This study is retrospectively registered at ClinicalTrials.gov NCT05311839.

31 October 2020 in Annals of Rehabilitation Medicine
Verified
Journal Article
Open access
PDF file
FKFatmaAlzahraa Hassan Kamel
FatmaAlzahraa Hassan Kamel
MBMaged A Basha
Maged A Basha
AAAshwag Alsharidah
Ashwag Alsharidah
IHIslam Mohamed Hewidy
Islam Mohamed Hewidy
MEMohamed Ezzat
Mohamed Ezzat
NANancy Hassan Aboelnour
Nancy Hassan Aboelnour
Objective To investigate the efficacy of extracorporeal shockwave therapy (ESWT) on cervical myofascial pain following neck dissection in reducing pain and improving cervical range of motion (ROM).Methods Forty-six patients with cervical myofascial pain following neck dissection surgery were recruited and subdivided at random into two equal groups. The ESWT group received ESWT once a week for 4 weeks (0.25 mL/mm2, 1,000 shocks) and a topical non-steroidal anti-inflammatory drug (3 times/day for 4 weeks). The control group received only topical NSAID. The pain assessment was done by using the visual analog scale (VAS) and pressure algometry. A cervical ROM device was used for the assessment of the lateral flexion and rotation of the neck ROM on both sides. All measurements were collected at baseline, 2 weeks, and 4 weeks.Results The ESWT group revealed a significant improvement in all parameters at post I and post II than did the control group (p>0.001), that revealed a statistical decrease only in the VAS score at post I without any statistical difference in the pain threshold and neck ROM. However, there were statistical differences in all parameters at post II compared to those at pre-treatment and post I (p<0.001).Conclusion As a confirmation of the efficacy of ESWT in cervical myofascial pain control following neck dissection, we observed better results with no side effects in the ESWT group (Clinical Trial Registry No. PACTR202002648274347).